Your session is about to expire
← Back to Search
Behavioural Intervention
Intervention for Urinary Incontinence
N/A
Waitlist Available
Led By Dean S Elterman, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months follow-up
Awards & highlights
No Placebo-Only Group
Summary
The rationale for the conduct of this study is that the Intone device (along with pelvic physiotherapy) can be used to help females suffering from urinary stress incontinence by using electrical stimulation and biofeedback during pelvic floor muscle training. This investigation is important because it can aid in the greater acceptance and development of non-surgical treatments for Stress Urinary Incontinence if these areas are looked into. The study results will address if the Intone device is beneficial and promotes long-term improvement in women that suffer from urinary incontinence.
Eligible Conditions
- Urinary Incontinence
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pad Test Weighting
Secondary study objectives
48 Hour Bladder Diary
Incontinence Impact Questionnaire Short Form (IIQ-7)
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ UI SF)
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Participants will undergo the InTone TM (InControl Medical, LLC) medical device treatment for Urinary Incontinence. The frequency of treatment is once/day (12 minutes), 5-6 days/week. The route of administration is vaginal.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,520 Previous Clinical Trials
503,214 Total Patients Enrolled
Dean S Elterman, MDPrincipal InvestigatorUniversity Health Network, Toronto
Share this study with friends
Copy Link
Messenger